In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Crescent Diagnostics brings in €1.5mm through its Series A round

Executive Summary

Crescent Diagnostics Ltd. (test for risk of hip fractures) has raised €1.5mm ($2.2mm) through its Series A venture round. Participants included AIB Seed Capital Fund (co-managed by Enterprise Equity Venture Capital), Bank of Ireland Seed Fund (managed by Kernel Capital), and current shareholder Seroba BioVentures.
Deal Industry
  • In Vitro Diagnostics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register